Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jilong Yang"'
Autor:
Ruwei Xing, Zhichao Liao, Jilong Yang, Jonathan C. Trent, Yun Yang, Jun Zhao, Xiangchun Li, Hui Yu, Yongtian Zhao, Zhiwu Ren, Sheng Teng, Haixiao Wu, Kexin Chen, Jia Lu, Ting Li
Publikováno v:
Cancer biologymedicine. 19(6)
Objective: Sarcomas are a group of rare malignancies with various subtypes. Patients with metastatic sarcoma who have failed traditional treatments can possibly achieve better prognoses from using novel therapies, including anti-programmed death-1 (P
Autor:
Jilong Yang, Yuhua Li, Xuan Zhou, Ze Tan, Sanfang Tu, Weijun Zhou, Meifang Li, Yanjie He, Lenghe Zhang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-15 (2019)
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research : CR
Background Epidermal growth factor receptor (EGFR) and epidermal growth factor receptor pathway substrate 8 (Eps8) have been widely reported to be expressed in various tumors. Eps8 is an important active kinase substrate of EGFR that directly binds t
Autor:
Xu Bai, Xinwei Zhang, Jilong Yang, Gang Zhao, Liang Liu, Chao Zhang, Ting Li, Wei Zhang, Mengze Hao, Da Yang, Min Zhang, Kexin Chen, Farideh Mehraein-Ghomi, Hong Zheng, Shafat Hassan
Publikováno v:
Cancer Lett
Immunotherapy targeting the PD-1/PD-L1 receptor has achieved great success in melanoma patients. Although many studies have addressed the underlying mechanisms involved in the blockade of PD-1/PD-L1 and the consequent modulation of the immune system,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b09b5d18c994d3843a94caf218fe00e
https://europepmc.org/articles/PMC7816098/
https://europepmc.org/articles/PMC7816098/
Autor:
Zhao Liang, Jingwen Du, Chaoyang Song, Lenghe Zhang, Rui Huang, Yanjie He, Chunyan Yue, Xuan Zhou, Lung-Ji Chang, Peihua Cao, Zhenling Guo, Jilong Yang, Sanfang Tu, Yuchen Li, Lan Deng, Yuhua Li
Publikováno v:
American Journal of Hematology. 94
Autor:
Zhaoming Ye, Jianhua Lin, Jingnan Shen, Tao Li, Hairong Xu, Feng Wei, Jianmin Li, Xiaojing Zhang, Xiaohui Niu, Guochuan Zhang, Dong Wang, Chongqi Tu, Wangjun Yan, Yuhong Zhou, Zheng Guo, Weitao Yao, Jilong Yang, Zhichao Tong, Wenzhi Bi, Gang Huang
Publikováno v:
Journal of Clinical Oncology. 39:11526-11526
11526 Background: JMT103 is a novel, fully humanized IgG4 monoclonal antibody targeting RANKL, inhibiting osteoclastogenesis and osteoclast-mediated bone resorption. A multicenter, single-arm, open-label, phase Ib/II study was conducted to evaluate t
Autor:
Wei Zhao, Qingzhong Yu, Wen Guoyuan, Zhenyu Zhang, Jilong Yang, Laszlo Zsak, Yufeng Li, Maricarmen García, Stephen J. Spatz
Publikováno v:
Vaccine. 35:789-795
Newcastle disease virus (NDV) recombinants expressing the infectious laryngotracheitis virus (ILTV) glycoproteins B and D have previously been demonstrated to confer complete clinical protection against virulent ILTV and NDV challenges in naive chick
Autor:
Kexin Chen, Chao Zhang, Fengju Song, Xinyue Liu, Ting Li, Jilong Yang, Wei Zhang, Shafat Hassan
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-10 (2018)
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-10 (2018)
Histone acetylation and deacetylation are important epigenetic mechanisms that regulate gene expression and transcription. Histone deacetylase 6 (HDAC6) is a unique member of the HDAC family that not only participates in histone acetylation and deace
Autor:
Yaxiong Zhang, Muhammad Nawaz, Jeffrey I. Cohen, Chunlin Ou, Jilong Yang, Ming-Yuan Chen, Wei Jie Tian, Li Zhang, Farah Fatima, Wei Bu, Jun-Ping Yun
Publikováno v:
Chinese Journal of Cancer
To accelerate our endeavors to overcome cancer, Chinese Journal of Cancer has launched a program of publishing 150 most important questions in cancer research and clinical oncology. In this article, 9 more questions are presented as follows. Question
Autor:
Jilong Yang, Rashi Bharat Patel, Jivani Aakash Jaldeepbhai, H A Pavanika N V Perera, Zhichao Liao, Dholiya Hardeep Dhirubhai, Vaibhav Singh, Xiaoling Du, Sujani Kaushalya Muthukuda, Ting Li
Liposarcomas (LPS) are among the most common soft tissue sarcomas, originating from adipocytes. Treatment for LPS typically involves surgical resection and radiation therapy, while the use of conventional cytotoxic chemotherapy for unresectable or me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7953fa9afdca36dd88a49837fcb4280
https://europepmc.org/articles/PMC5388671/
https://europepmc.org/articles/PMC5388671/
Autor:
Wei Zhang, Jilong Yang
Publikováno v:
Current Opinion in Oncology. 25:398-406
Recent translational studies in osteosarcoma are discussed with the purpose to shed light on the new molecular therapeutic targets.The genetic aberrations of vascular endothelial growth factor (VEGF), mammalian target of rapamycin, Wnt signaling path